Volume 2, Issue 3 (Summer 2021)
J Vessel Circ 2021, 2(3): 121-128 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Saghafi H, Haghighi Z, Tabrizi L, Havaeji S S, Vahedian M, Komeili Movahed T et al . Serum Neutrophil Gelatinase-associated Lipocalin: A Biomarker of Renal Impairment in Hypertensive Patients. J Vessel Circ 2021; 2 (3) :121-128
URL: http://jvessels.muq.ac.ir/article-1-155-en.html
URL: http://jvessels.muq.ac.ir/article-1-155-en.html
Hossein Saghafi1 
, Zahra Haghighi2 , Leila Tabrizi3 , Saade Sadat Havaeji3 , Mostafa Vahedian4 , Tahereh Komeili Movahed * 3, Abdollah Jafari Taheri5
, Zahra Haghighi2 , Leila Tabrizi3 , Saade Sadat Havaeji3 , Mostafa Vahedian4 , Tahereh Komeili Movahed * 3, Abdollah Jafari Taheri5
1- Department of Internal Medicine, School of Medicine, Qom University of Medical Sciences, Qom, Iran., Department of Internal Medicine, School of Medicine, Qom university of Medical Sciences, Qom, Iran
2- Cancer Research Laboratory, Department of Clinical Biochemistry, School of Medical Sciences,Tarbiat Modares University, Tehran, Iran., Cancer Research Laboratory,Department of Clinical Biochemistry, School of Medical Sciences,Tarbiat Modares University (TMU), Tehran, Iran
3- Cellular & Molecular Research Center, Qom University of Medical Sciences, Qom, Iran., Cellular & Molecular Research Center, Qom university of Medical Sciences, Qom, Iran
4- Department of Epidemiology and Biostatistics, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran., Department of Epidemiology and Biostatistics, Faculty of Medicine , Qom university of Medical Sciences, Qom, Iran
5- Department of Cardiology, Kamkar-Arabnia Hospital, Qom University of Medical Sciences, Qom, Iran, Department of Cardiology, Kamkar-Arabnia Hospital, Qom university of Medical Sciences, Qom, Iran
2- Cancer Research Laboratory, Department of Clinical Biochemistry, School of Medical Sciences,Tarbiat Modares University, Tehran, Iran., Cancer Research Laboratory,Department of Clinical Biochemistry, School of Medical Sciences,Tarbiat Modares University (TMU), Tehran, Iran
3- Cellular & Molecular Research Center, Qom University of Medical Sciences, Qom, Iran., Cellular & Molecular Research Center, Qom university of Medical Sciences, Qom, Iran
4- Department of Epidemiology and Biostatistics, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran., Department of Epidemiology and Biostatistics, Faculty of Medicine , Qom university of Medical Sciences, Qom, Iran
5- Department of Cardiology, Kamkar-Arabnia Hospital, Qom University of Medical Sciences, Qom, Iran, Department of Cardiology, Kamkar-Arabnia Hospital, Qom university of Medical Sciences, Qom, Iran
Abstract: (1093 Views)
Background and Aim: Hypertension is one of the leading causes of chronic kidney disease (CKD). Neutrophil gelatinase-associated lipocalin (NGAL) is a novel and sensitive biomarker in acute and chronic renal injury. The present study investigated serum and urinary NGAL as markers of kidney damage in hypertensive and CKD patients.
Materials and Methods: This case-control study was performed on 28 hypertensive patients, 28 patients with CKD, and 33 healthy volunteers. Serum and urinary NGAL levels were measured using the ELISA method. Creatinine and urea concentrations were measured by the routine methods. Receiver-operating characteristic (ROC) curve analysis was employed to find the best serum and urinary NGAL cut-off values for detecting renal function.
Results: Both serum and urinary NGAL levels were higher in CKD patients than in hypertensive patients and healthy controls (serum NGAL: 193.48±50.62 vs 99.47±26.65 and 48.74±12.07, P<0.001; urinary NGAL: 63.78±16.54 vs 23.24±6.87 and 11.36±3.4, P<0.001 respectively). There was a significant positive correlation between serum and urinary NGAL with serum urea and creatinine. Serum and urinary NGAL levels showed a significant inverse correlation with the estimated glomerular filtration rate. In ROC analysis, serum NGAL had the best diagnostic profile with an AUC of 0.938 (95% CI: 0.865–0.978) and the best cut-off value of 64.61 ng/mL (sensitivity 97.73%; specificity 77.27%.
Conclusion: These results revealed that serum NGAL is a reliable marker for early diagnosis of renal injury in hypertensive patients
Materials and Methods: This case-control study was performed on 28 hypertensive patients, 28 patients with CKD, and 33 healthy volunteers. Serum and urinary NGAL levels were measured using the ELISA method. Creatinine and urea concentrations were measured by the routine methods. Receiver-operating characteristic (ROC) curve analysis was employed to find the best serum and urinary NGAL cut-off values for detecting renal function.
Results: Both serum and urinary NGAL levels were higher in CKD patients than in hypertensive patients and healthy controls (serum NGAL: 193.48±50.62 vs 99.47±26.65 and 48.74±12.07, P<0.001; urinary NGAL: 63.78±16.54 vs 23.24±6.87 and 11.36±3.4, P<0.001 respectively). There was a significant positive correlation between serum and urinary NGAL with serum urea and creatinine. Serum and urinary NGAL levels showed a significant inverse correlation with the estimated glomerular filtration rate. In ROC analysis, serum NGAL had the best diagnostic profile with an AUC of 0.938 (95% CI: 0.865–0.978) and the best cut-off value of 64.61 ng/mL (sensitivity 97.73%; specificity 77.27%.
Conclusion: These results revealed that serum NGAL is a reliable marker for early diagnosis of renal injury in hypertensive patients
Type of Study: Research |
Subject:
vascular nephrology
Received: 2021/10/8 | Accepted: 2021/10/18 | Published: 2021/12/1
Received: 2021/10/8 | Accepted: 2021/10/18 | Published: 2021/12/1
References
1. Chockalingam A, Campbell NR, George Fodor J. Worldwide epidemic of hypertension. Can J Cardiol. 2006; 22(7):553-5. [DOI:10.1016/S0828-282X(06)70275-6] [DOI:10.1016/S0828-282X(06)70275-6]
2. Ng JK, Li PK. Chronic kidney disease epidemic: How do we deal with it? Nephrology (Carlton). 2018; 23(Suppl 4):116-20. [DOI:10.1111/nep.13464] [PMID] [DOI:10.1111/nep.13464]
3. Ozkan S, Durukan P, Kavalci C, Duman A, Sayhan MB, Salt O, et al. Importance of neutrophil gelatinase-associated lipocalin in differential diagnosis of acute and chronic renal failure. Iran Red Crescent Med J. 2014; 16(8):e1413. [PMID] [PMCID] [DOI:10.5812/ircmj.14133]
4. Rysz J, Gluba-Brzozka A, Franczyk B, Jablonowski Z, Cialkowska-Rysz A. Novel biomarkers in the diagnosis of chronic kidney disease and the prediction of its outcome. Int J Mol Sci. 2017; 18(8):1702. [DOI:10.3390/ijms18081702] [PMID] [PMCID] [DOI:10.3390/ijms18081702]
5. Satirapoj B, Nast CC, Adler SG. Novel insights into the relationship between glomerular pathology and progressive kidney disease. Adv Chronic Kidney Dis. 2012; 19(2):93-100. [DOI:10.1053/j.ackd.2011.12.001] [PMID] [DOI:10.1053/j.ackd.2011.12.001]
6. Wang YN, Ma SX, Chen YY, Chen L, Liu BL, Liu QQ, et al. Chronic kidney disease: Biomarker diagnosis to therapeutic targets. Clin Chim Acta. 2019; 499:54-63. [DOI:10.1016/j.cca.2019.08.030] [PMID] [DOI:10.1016/j.cca.2019.08.030]
7. Yalman MV, Madendag Y, Sahin E, Madendag IC, Sahin ME, Acmaz G, et al. Effect of preeclampsia and its severity on maternal serum NGAL and KIM-1 levels during pregnancy and the post-pregnancy period. Eur J Obstet Gynecol Reprod Biol. 2020; 256:246-51. [DOI:10.1016/j.ejogrb.2020.11.040] [PMID] [DOI:10.1016/j.ejogrb.2020.11.040]
8. Zhen XW, Song NP, Ma L-H, Ma LN, Guo L, Yang XD. Calprotectin and neutrophil gelatinase-associated lipocalin as biomarkers of acute kidney injury in acute coronary syndrome. Am J Med Sci. 2021; 361(6):736-43. [DOI:10.1016/j.amjms.2020.10.028] [PMID] [DOI:10.1016/j.amjms.2020.10.028]
9. Srisawat N, Kellum JA. The role of biomarkers in acute kidney injury. Crit Care Clin. . 2020; 36(1):125-40. [DOI:10.1016/j.ccc.2019.08.010] [PMID] [DOI:10.1016/j.ccc.2019.08.010]
10. Amaral Pedroso L, Nobre V, Dias Carneiro de Almeida C, da Silva Praxedes MF, Sernizon Guimaraes N, Simoes ESAC, et al. Acute kidney injury biomarkers in the critically ill. Clin Chim Acta. 2020; 508:170-8. [DOI:10.1016/j.cca.2020.05.024] [PMID] [DOI:10.1016/j.cca.2020.05.024]
11. Han X, Zhang S, Chen Z, Adhikari BK, Zhang Y, Zhang J, et al. Cardiac biomarkers of heart failure in chronic kidney disease. Clinica Chimica Acta. 2020; 510:298-310. [DOI:10.1016/j.cca.2020.07.040] [PMID] [DOI:10.1016/j.cca.2020.07.040]
12. Solak Y, Yilmaz MI, Siriopol D, Saglam M, Unal HU, Yaman H, et al. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2015; 47(12):1993-2001. [DOI:10.1007/s11255-015-1136-4] [PMID] [DOI:10.1007/s11255-015-1136-4]
13. Moriya H, Mochida Y, Ishioka K, Oka M, Maesato K, Hidaka S, et al. Plasma neutrophil gelatinase-associated lipocalin (NGAL) is an indicator of interstitial damage and a predictor of kidney function worsening of chronic kidney disease in the early stage: A pilot study. Clin Exp Nephrol. 2017; 21(6):1053-9. [DOI:10.1007/s10157-017-1402-0] [PMID] [DOI:10.1007/s10157-017-1402-0]
14. Charles C, Ferris AH. Chronic kidney disease. Prim Care. 2020; 47(4):585-95. [DOI:10.1016/j.pop.2020.08.001] [PMID] [DOI:10.1016/j.pop.2020.08.001]
15. Noble R, Taal MW. Epidemiology and causes of chronic kidney disease. Medicine. 2019; 47(9):562-6. [DOI:10.1016/j.mpmed.2019.06.010] [DOI:10.1016/j.mpmed.2019.06.010]
16. Bidin MZ, Shah AM, Stanslas J, Seong CLT. Blood and urine biomarkers in chronic kidney disease: An update. Clin Chim Acta. 2019; 495:239-50. [DOI:10.1016/j.cca.2019.04.069] [PMID] [DOI:10.1016/j.cca.2019.04.069]
17. Quang TH, Nguyet MP, Thao DP, Thi MH, Phuong Thi Dam L, Thi HH, et al. Evaluation of urinary neutrophil gelatinase associated lipocalin and kidney injury molecule-1 as diagnostic markers for early nephropathy in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2020; 13:2199-207. [DOI:10.2147/DMSO.S258678] [PMID] [PMCID] [DOI:10.2147/DMSO.S258678]
18. Woo KS, Choi JL, Kim BR, Kim JE, An WS, Han JY. Urinary neutrophil gelatinase-associated lipocalin levels in comparison with glomerular filtration rate for evaluation of renal function in patients with diabetic chronic kidney disease. Diabetes Metab J. 2012; 36(4):307-13. [DOI:10.4093/dmj.2012.36.4.307] [PMID] [PMCID] [DOI:10.4093/dmj.2012.36.4.307]
19. Aksan G, İnci S, Nar G, Siğirci S, Gedikli Ö, Soylu K, et al. Serum neutrophıl gelatınase-assocıated lıpocalın levels in patients with non-dipper hypertension. Clin Invest Med. 2015; 38(2):E53-62. [DOI:10.25011/cim.v38i1.22576] [PMID] [DOI:10.25011/cim.v38i1.22576]
20. Gharishvandi F, Kazerouni F, Ghanei E, Rahimipour A, Nasiri M. Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension. Iran Biomed J. 2015; 19(2):76-81. [DOI:10.6091/ibj.1380.2015] [PMID] [PMCID]
21. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4(2):337-44. [DOI:10.2215/CJN.03530708] [PMID] [PMCID] [DOI:10.2215/CJN.03530708]
22. Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Pawlak K, Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease. Nephrology (Carlton). 2008; 13(2):153-6. [DOI:10.1111/j.1440-1797.2007.00899.x] [PMID] [DOI:10.1111/j.1440-1797.2007.00899.x]
23. Peralta CA, Whooley MA, Ix JH, Shlipak MG. Kidney function and systolic blood pressure new insights from cystatin c: Data from the heart and soul study. Am J Hypertens. 2006; 19(9):939-46. [DOI:10.1016/j.amjhyper.2006.02.007] [PMID] [PMCID] [DOI:10.1016/j.amjhyper.2006.02.007]
24. Du W, Shen T, Li H, Liu Y, He L, Tan L, et al. Urinary NGAL for the diagnosis of the renal injury from multiple myeloma. Cancer Biomark. 2017; 18(1):41-6. [DOI:10.3233/CBM-160672] [PMID] [DOI:10.3233/CBM-160672]
25. Kaul A, Behera MR, Rai MK, Mishra P, Bhaduaria DS, Yadav S, et al. Neutrophil gelatinase-associated lipocalin: As a predictor of early diabetic nephropathy in type 2 diabetes mellitus. Indian J Nephrol. 2018; 28(1):53-60. [DOI:10.4103/ijn.IJN_96_17] [PMID] [PMCID] [DOI:10.4103/ijn.IJN_96_17]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Owned by Qom University of Medical Sciences
Published by Qom University of Medical Sciences Press
eISSN: 2717-0357
Email: jvessels[at]muq.ac.ir
j.vessels.circul[at]gmail.com
